These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10804838)

  • 1. [Quantitation of human immunodeficiency virus type 1 RNA by ultrasensitive method in the analysis of samples with low viral load].
    Nishida Y; Moriya K; Nagaizumi K; Inaba H; Amano K; Fukue H; Yamamoto Y; Arai M; Fukutake K
    Rinsho Byori; 2000 Mar; 48(3):282-3. PubMed ID: 10804838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter.
    Piwowar-Manning EM; Henderson TA; Brisbin L; Jackson JB
    Am J Clin Pathol; 2003 Aug; 120(2):268-70. PubMed ID: 12931558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load.
    Villahermosa ML; Thomson M; Vázquez de Parga E; Cuevas MT; Contreras G; Pérez-Alvarez L; Delgado E; Manjón N; Medrano L; Nájera R
    J Hum Virol; 2000; 3(1):27-34. PubMed ID: 10774804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load.
    Jackson JB; Piwowar-Manning E; Johnson-Lewis L; Bassett R; Demeter LM; Brambilla D
    J Clin Microbiol; 2004 Jun; 42(6):2774-6. PubMed ID: 15184467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 3 nucleic acid isolation methods for the quantification of HIV-1 RNA by Cobas Taqman real-time polymerase chain reaction system.
    Alp A; Hascelik G
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):365-71. PubMed ID: 19232859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.
    Choi JY; Kim EJ; Rho HJ; Kim JY; Kwon OK; Lee JH; Koo MJ; Kim SS
    J Virol Methods; 2009 Oct; 161(1):7-11. PubMed ID: 19576640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay.
    Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Borodowsky I; Subbakrishna DK; Kumar M
    J Clin Virol; 2007 May; 39(1):9-15. PubMed ID: 17368087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology.
    Todd J; Pachl C; White R; Yeghiazarian T; Johnson P; Taylor B; Holodniy M; Kern D; Hamren S; Chernoff D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S35-44. PubMed ID: 7552511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy.
    Percus JK; Percus OE; Markowitz M; Ho DD; Di Mascio M; Perelson AS
    Bull Math Biol; 2003 Mar; 65(2):263-77. PubMed ID: 12675332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.
    Hoesley CJ; Saag MS; Chatham A; Kilby JM
    Clin Infect Dis; 2000 Oct; 31(4):1095-7. PubMed ID: 11049795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia.
    Mackie N; Dustan S; McClure MO; Weber JN; Clarke JR
    J Virol Methods; 2004 Aug; 119(2):73-8. PubMed ID: 15158587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1.
    García-Bujalance S; Ladrón de Guevara C; González-García J; Arribas JR; Zamora F; Gutiérrez A
    J Microbiol Methods; 2007 May; 69(2):384-6. PubMed ID: 17363096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.
    Elbeik T; Hoo BS; Campodonico ME; Dileanis J; Fay FF; Bortolozzi RL; Benetti MS; Fay OH; Marlowe N; Petrauskene O; Chernoff D; Smith L; Ng VL
    J Hum Virol; 2001; 4(6):317-28. PubMed ID: 12082398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.
    Bonora S; Nicastri E; Calcagno A; Gonzalez de Requena D; D'Ettorre G; Sarmati L; Palmisano L; Vullo V; Di Perri G; Andreoni M
    J Med Virol; 2009 Mar; 81(3):400-5. PubMed ID: 19152404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Sun R; Ku J; Jayakar H; Kuo JC; Brambilla D; Herman S; Rosenstraus M; Spadoro J
    J Clin Microbiol; 1998 Oct; 36(10):2964-9. PubMed ID: 9738051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.